FDA Seizes $24.2 Million In Unapproved Drugs From KV Pharmaceutical

On July 29, 2008, the St. Louis Business Journal reported the seizure of $24.2 million worth of unapproved drugs from a KV Pharmaceutical Company warehouse in St. Louis.  Food & Drug Administration inspectors found that KV was not complying with an enforcement notice requiring drugs in time-release format containing guaifenesin to be approved in order to ensure safe and effective release of the active ingredients. The majority of the products seized were manufactured after the FDA required an end to their production. In addition, the inspectors found the company was manufacturing and distributing other unapproved drugs, such as products for cough, cold, topical wound healing, skin bleaching and gastrointestinal conditions. If you are seeing fraud on the government, contact us by calling 800-377-1812 for strictly confidential advice from experienced counsel, with no fee obligation.